Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

1.

Preservation of renal function during gout treatment with febuxostat: a quantitative study.

Whelton A, MacDonald PA, Chefo S, Gunawardhana L.

Postgrad Med. 2013 Jan;125(1):106-14. doi: 10.3810/pgm.2013.01.2626.

PMID:
23391676
[PubMed - indexed for MEDLINE]
2.

Urate-lowering therapy for gout: focus on febuxostat.

Love BL, Barrons R, Veverka A, Snider KM.

Pharmacotherapy. 2010 Jun;30(6):594-608. doi: 10.1592/phco.30.6.594. Review.

PMID:
20500048
[PubMed - indexed for MEDLINE]
3.

Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis.

Ye P, Yang S, Zhang W, Lv Q, Cheng Q, Mei M, Luo T, Liu L, Chen S, Li Q.

Clin Ther. 2013 Feb;35(2):180-9. doi: 10.1016/j.clinthera.2012.12.011. Epub 2013 Jan 16. Review.

PMID:
23332451
[PubMed - indexed for MEDLINE]
4.

Febuxostat: a new treatment for hyperuricaemia in gout.

Edwards NL.

Rheumatology (Oxford). 2009 May;48 Suppl 2:ii15-ii19. doi: 10.1093/rheumatology/kep088. Review.

PMID:
19447778
[PubMed - indexed for MEDLINE]
Free Article
5.

Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.

Stevenson M, Pandor A.

Health Technol Assess. 2009 Oct;13 Suppl 3:37-42. doi: 10.3310/hta13suppl3/06. Review.

PMID:
19846027
[PubMed - indexed for MEDLINE]
Free Article
6.

Febuxostat for treating chronic gout.

Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008653. doi: 10.1002/14651858.CD008653.pub2. Review.

PMID:
23152264
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Febuxostat.

Hair PI, McCormack PL, Keating GM.

Drugs. 2008;68(13):1865-74. Review.

PMID:
18729537
[PubMed - indexed for MEDLINE]
8.

Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.

Ernst ME, Fravel MA.

Clin Ther. 2009 Nov;31(11):2503-18. doi: 10.1016/j.clinthera.2009.11.033. Review.

PMID:
20109996
[PubMed - indexed for MEDLINE]
9.

A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout.

Faruque LI, Ehteshami-Afshar A, Wiebe N, Tjosvold L, Homik J, Tonelli M.

Semin Arthritis Rheum. 2013 Dec;43(3):367-75. doi: 10.1016/j.semarthrit.2013.05.004. Review.

PMID:
24326033
[PubMed - indexed for MEDLINE]
10.

Management of hyperuricemia in gout: focus on febuxostat.

Reinders MK, Jansen TL.

Clin Interv Aging. 2010 Feb 2;5:7-18. Review.

PMID:
20169038
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Febuxostat: a novel non-purine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in gout.

Yu KH.

Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):69-75. Review.

PMID:
19075968
[PubMed - indexed for MEDLINE]
12.

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal.

Stevenson M, Pandor A.

Pharmacoeconomics. 2011 Feb;29(2):133-40. doi: 10.2165/11535770-000000000-00000. Review.

PMID:
21155617
[PubMed - indexed for MEDLINE]
13.

Febuxostat: a new agent for lowering serum urate.

Keenan RT, Pillinger MH.

Drugs Today (Barc). 2009 Apr;45(4):247-60. doi: 10.1358/dot.2009.45.4.1354217. Review.

PMID:
19499090
[PubMed - indexed for MEDLINE]
14.

A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout.

Chao J, Terkeltaub R.

Curr Rheumatol Rep. 2009 Apr;11(2):135-40. Review.

PMID:
19296886
[PubMed - indexed for MEDLINE]
15.

Febuxostat for treatment of chronic gout.

Gray CL, Walters-Smith NE.

Am J Health Syst Pharm. 2011 Mar 1;68(5):389-98. doi: 10.2146/ajhp100394. Review.

PMID:
21330679
[PubMed - indexed for MEDLINE]
16.

Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.

Bruce SP.

Ann Pharmacother. 2006 Dec;40(12):2187-94. Epub 2006 Nov 28. Review.

PMID:
17132810
[PubMed - indexed for MEDLINE]
17.

A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout.

Naoyuki K, Tatsuo H.

J Clin Rheumatol. 2011 Jun;17(4 Suppl 2):S11-2. doi: 10.1097/RHU.0b013e31821d479d. Review. No abstract available.

PMID:
21654264
[PubMed - indexed for MEDLINE]
18.

Uricase and other novel agents for the management of patients with treatment-failure gout.

Sundy JS, Hershfield MS.

Curr Rheumatol Rep. 2007 Jun;9(3):258-64. Review.

PMID:
17531181
[PubMed - indexed for MEDLINE]
19.

[Gout: an overview of available urate lowering therapies].

Richette P.

Ann Pharm Fr. 2012 May;70(3):133-8. doi: 10.1016/j.pharma.2012.02.003. Epub 2012 Apr 27. Review. French.

PMID:
22655581
[PubMed - indexed for MEDLINE]
20.

Febuxostat (Uloric) for chronic treatment of gout.

[No authors listed]

Med Lett Drugs Ther. 2009 May 18;51(1312):37-8. Review.

PMID:
19448587
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk